Follow the COVID Money

Follow the COVID Money. By Jeffrey Barke.

In 2020 big pharma spent over $300 million lobbying officeholders and government officials. It clearly pays off. The research to develop the COVID-19 vaccines was nearly all funded by taxpayers. The distribution of the vaccines, once developed, was further funded nearly entirely by taxpayers. The record-keeping and reporting on the vaccines is also at the expense of taxpayers, and the new repurposed Pfizer drug Paxlovid, used to treat COVID, has been paid for by taxpayers. …

The pharmaceutical industry is said to spend $5.2 billion annually on television advertising aimed primarily at the consumer. It poured another $9.53 billion into digital advertising aimed at consumers and industry in 2020. This total of nearly $15 billion spent by Big Pharma on advertising is more than twice what is spent on new cancer drug research.

Almost half of the funding that supports the U.S. Food and Drug Administration comes from the very industries it is mandated to oversee. CDC funding is similar. But it also receives large grants for COVID research from the Bloomberg Family Foundation and the Bill and Melinda Gates Foundation. … Present and former NIH researchers received annual royalty payments averaging $9,700 in addition to their taxpayer-funded, biweekly paychecks. Some have been reported to receive as much as $150,000 in annual royalty rewards! …

Pfizer expects $32 billion in COVID vaccine sales in 2022. Moderna is forecasting $19 billion in COVID sales with the vaccine being its only current commercial product. …

Big pharmacy chains are also participating in this government largess as well. The big chains earn “…roughly $40 per shot” from the federal government. Since the government provides the pharmacy chains with the vaccines and Paxlovid for free, almost all their charge for administering the shots or dispensing the drug is profit.

After a while they printed so much new money that even the voters began to sit up and take notice.